المؤلفون: Francesca Bizzaro (807010), Ilaria Fuso Nerini (170861), Molly A. Taylor (11657469), Alessia Anastasia (11657472), Massimo Russo (6710120), Giovanna Damia (426340), Federica Guffanti (807009), Francesca Guana (10215509), Paola Ostano (141378), Lucia Minoli (4642330), Maureen M. Hattersley (5545526), Stephanie Arnold (11657475), Antonio Ramos-Montoya (1988161), Stuart C. Williamson (11657478), Alessandro Galbiati (2385031), Jelena Urosevic (11657481), Elisabetta Leo (16336), Ugo Cavallaro (9331613), Carmen Ghilardi (64686), Simon T. Barry (9174377), Maria Rosa Bani (11657484), Raffaella Giavazzi (64690)

مصطلحات موضوعية: Biochemistry, Genetics, Molecular Biology, Pharmacology, Cancer, Science Policy, Hematology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Ovarian cancer, Patient-derived xenograft, PARP inhibitor, VEGF pathway inhibitor, BRCA, Olaparib, Cediranib

العلاقة: https://figshare.com/articles/journal_contribution/Additional_file_1_of_VEGF_pathway_inhibition_potentiates_PARP_inhibitor_efficacy_in_ovarian_cancer_independent_of_BRCA_status/16944627Test

الإتاحة: https://doi.org/10.6084/m9.figshare.16944627.v1Test

المؤلفون: Francesca Bizzaro (807010), Ilaria Fuso Nerini (170861), Molly A. Taylor (11657469), Alessia Anastasia (11657472), Massimo Russo (6710120), Giovanna Damia (426340), Federica Guffanti (807009), Francesca Guana (10215509), Paola Ostano (141378), Lucia Minoli (4642330), Maureen M. Hattersley (5545526), Stephanie Arnold (11657475), Antonio Ramos-Montoya (1988161), Stuart C. Williamson (11657478), Alessandro Galbiati (2385031), Jelena Urosevic (11657481), Elisabetta Leo (16336), Ugo Cavallaro (9331613), Carmen Ghilardi (64686), Simon T. Barry (9174377), Maria Rosa Bani (11657484), Raffaella Giavazzi (64690)

مصطلحات موضوعية: Biochemistry, Genetics, Molecular Biology, Pharmacology, Cancer, Science Policy, Hematology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Ovarian cancer, Patient-derived xenograft, PARP inhibitor, VEGF pathway inhibitor, BRCA, Olaparib, Cediranib

العلاقة: https://figshare.com/articles/journal_contribution/Additional_file_2_of_VEGF_pathway_inhibition_potentiates_PARP_inhibitor_efficacy_in_ovarian_cancer_independent_of_BRCA_status/16944630Test

الإتاحة: https://doi.org/10.6084/m9.figshare.16944630.v1Test